A Study to Assess the Safety and Tolerability of Single Doses of AZD4076 in Healthy Male Subjects
Clinical trial NCT02612662 · COMPLETED
Trial details
- NCT number
- NCT02612662
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-24
- Primary completion
- 2017-11-04
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.